The Injectable Cytotoxic Drugs Market is positioned for steady expansion, driven by the rising global burden of cancer and the sustained demand for effective chemotherapy regimens. Valued at US$ 19,625 Million in 2024, the market is projected to expand at a CAGR of 6.50% from 2025 to 2032. Injectable cytotoxic drugs remain a cornerstone of oncology treatment protocols, particularly for aggressive and advanced-stage malignancies where systemic therapeutic intervention is essential. Market...